Lesch-Nyhan Syndrome
RareMetabolic
Lesch-Nyhan Syndrome is treated with 2 medications in our database, including OXLUMO, RIVFLOZA. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Alnylam, Novo Nordisk. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Lesch-Nyhan Syndrome treatment below.
What help exists for Lesch-Nyhan Syndrome
2
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Lesch-Nyhan Syndrome
2 total🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Lesch-Nyhan Syndrome drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | Yes | — | — |
Lesch-Nyhan Syndrome is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →